Neonatal hypothyroidism detected by the Northwest Regional Screening Program

Area of Science:

• Pediatrics
• Endocrinology
• Public Health

Background:

• Congenital hypothyroidism (CH) is a critical condition requiring early detection and treatment to prevent developmental issues.
• Neonatal screening programs are vital for identifying CH in asymptomatic infants.
• The Northwest Regional Screening Program was established to screen infants in Oregon, Montana, Alaska, and Idaho.

Purpose of the Study:

• To evaluate the effectiveness and efficiency of the Northwest Regional Screening Program for congenital hypothyroidism.
• To determine the incidence of primary hypothyroidism and thyroxine-binding globulin deficiency in the screened population.
• To assess the diagnostic approach and associated costs.

Main Methods:

• Utilized dried blood filter paper specimens collected from newborns in four states.
• Implemented a two-tiered screening strategy: initial thyroxine (T4) measurement followed by thyroid-stimulating hormone (TSH) testing for low T4 values.
• Confirmed diagnoses with serum samples via venipuncture.

Main Results:

• Detected 25 cases of primary hypothyroidism (1:4,430) and 14 cases of thyroxine-binding globulin deficiency (1:7,900) in 110,667 infants.
• Achieved a low repeat specimen request rate (0.4% in Oregon, 0.05% in other states) with the T4/TSH approach.
• Identified common etiologies including thyroid aplasia, ectopic gland, hypoplasia, and goiter.

Conclusions:

• The screening program successfully identified infants with congenital hypothyroidism, many lacking clinical signs.
• The T4 followed by TSH testing strategy is efficient and cost-effective for neonatal screening.
• Early diagnosis and treatment, ideally by one month of age, are achievable and crucial for infant prognosis.